Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
about
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionThe Role of Obstetrician/Gynecologists in the Management of Hepatitis C Virus InfectionImpact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data--the ANRS-Coquelicot Study.A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.A trial to reduce hepatitis C seroincidence in drug users.Hepatitis C infection in non-treatment-seeking heroin users: the burden of cocaine injectionHIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis.Risk factors associated with Hepatitis C among female substance users enrolled in community-based HIV prevention studiesFactors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventionsRisk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.Hepatitis infection in the treatment of opioid dependence and abuse.Updating the infection risk reduction hierarchy: preventing transition into injection.Non-injection drug use and Hepatitis C Virus: a systematic review.Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.Sampling and recruitment in multilevel studies among marginalized urban populations: the IMPACT studies.Maintenance therapy with opium tincture for injecting drug users; implications for prevention from viral infectionsMajor decline of hepatitis C virus incidence rate over two decades in a cohort of drug usersViral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients.Prevalence of hepatitis C infection in New York City, 2004Differences in sociodemographic, drug use and health characteristics between never, former and current injecting, problematic hard-drug users in the NetherlandsThe histopathology of drugs of abuse.Comparison of HIV risk by duration of injection drug use.Injection risk behavior among women syringe exchangers in San Francisco.Hepatitis C virus infection among homeless men referred from a community clinic.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study.Trends in testing behaviours for hepatitis C virus infection and associated determinants: results from population-based laboratory surveillance in Alberta, Canada (1998-2001).Patterns of Non-injection Drug Use Associated with Injection Cessation among Street-Involved Youth in Vancouver, Canada.Increased Risk of Hepatocellular Carcinoma Associated With Neighborhood Concentrated Disadvantage
P2860
Q27485372-DDC26C9B-F130-499D-B6BF-A097F00E1CFEQ27486939-6AA55A66-36BF-435A-B1FB-24F587F72A4AQ31062611-3BC74F41-A286-445D-AE54-A31F7B0DB5AFQ33483115-5090F3E1-BCA2-466A-969F-DA30D590D650Q33658861-713C5E3A-3447-429D-B017-0408B9B710AFQ33760646-62A35AC8-4C22-4B01-9728-4F9DC03CBAFAQ33777428-E648C3CF-7561-4E69-BFF7-CCC3F08829CCQ33872878-38823646-CFCA-44FB-BE7E-E455B6CDF6A8Q34545139-6F913F6E-B155-4519-A805-A490F885A597Q35032861-D5242C3C-E8F9-4D3F-8DEC-784761B9F243Q35389163-91F69CC2-CE7A-42BE-91EE-DA5F6BF699E7Q35718883-5A9B4380-5EFC-44E2-BD1E-A133B81D0593Q35844048-E3E9B522-9B0B-47C2-87A5-18FB68ACA6D0Q36169466-CCFEA342-714A-4F74-BB74-63D1CA291D9DQ36725027-EED1D2DC-4979-4064-A7CE-DFF501AE32AEQ36957076-8533AB92-D850-424D-80BE-20B2D80E4B07Q37429961-94D7DE34-FB87-425F-98EC-382E54548466Q37463420-FCB78DDA-30B4-4F0E-B72A-240AB63C7A83Q37470465-358A1FD9-D5DF-44DC-84A9-A565E1175D1EQ37588133-31E9F46D-7186-476F-9362-A33F896A6D0CQ37831963-D592CEE4-F68F-44A4-A540-A232B5153CABQ39970004-57A634D5-7605-408D-8509-D1DBD9B23DE3Q42671943-D4B16FB1-CF74-4A1A-97EC-2BC85CDBD8FDQ42684938-5CB53D6A-392A-43D5-BB8C-E597222926A9Q42720607-3783440D-B1EA-45AD-99E2-E186F2E82313Q42984796-A6CEBE88-8749-4D4D-8781-14D55D53E2AEQ43036716-9C6D2E7A-FC2C-4790-8092-DAD5560C78CEQ50103462-C3E6B455-7BB5-4747-91D2-D435118937FDQ58750606-48FD9335-01A3-4992-8CAE-1A94980280D1
P2860
Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hepatitis C incidence--a compa ...... n drug users in New York City.
@en
Hepatitis C incidence--a compa ...... n drug users in New York City.
@nl
type
label
Hepatitis C incidence--a compa ...... n drug users in New York City.
@en
Hepatitis C incidence--a compa ...... n drug users in New York City.
@nl
prefLabel
Hepatitis C incidence--a compa ...... n drug users in New York City.
@en
Hepatitis C incidence--a compa ...... n drug users in New York City.
@nl
P2093
P2860
P50
P356
P1476
Hepatitis C incidence--a compa ...... n drug users in New York City.
@en
P2093
Crystal M Fuller
Sandro Galea
Yingfeng Wu
P2860
P2888
P356
10.1093/JURBAN/JTH084
P577
2004-03-01T00:00:00Z
P5875
P6179
1051686894